hnRNPK-derived cell-penetrating peptide inhibits cancer cell survival

Krecic, 1999, hnRNP complexes: composition, structure, and function, Curr. Opin. Cell Biol., 11, 363, 10.1016/S0955-0674(99)80051-9 Bomsztyk, 1997, Diverse molecular interactions of the hnRNP K protein, FEBS Lett., 403, 113, 10.1016/S0014-5793(97)00041-0 Tomonaga, 1996, Activating transcription from single stranded DNA, Proc. Natl. Acad. Sci. U S A, 93, 5830, 10.1073/pnas.93.12.5830 Michelotti, 1996, Heterogeneous nuclear ribonucleoprotein K is a transcription factor, Mol. Cell Biol., 16, 2350, 10.1128/MCB.16.5.2350 Mikula, 2013, Heterogeneous nuclear ribonucleoprotein (HnRNP) K genome-wide binding survey reveals its role in regulating 3’-end RNA processing and transcription termination at the early growth response 1 (EGR1) gene through XRN2 exonuclease, J. Biol. Chem., 288, 24788, 10.1074/jbc.M113.496679 Li, 2019, HNRNPK maintains epidermal progenitor function through transcription of proliferation genes and degrading differentiation promoting mRNAs, Nat. Commun., 10, 4198, 10.1038/s41467-019-12238-x Shnyreva, 2000, Interaction of two multifunctional proteins. Heterogeneous nuclear ribonucleoprotein K and Y-box-binding protein, J. Biol. Chem., 275, 15498, 10.1074/jbc.275.20.15498 Samuel, 1998, In situ cross-linking by cisplatin of nuclear matrix-bound transcription factors to nuclear DNA of human breast cancer cells, Cancer Res., 58, 3004 Pintacuda, 2017, hnRNPK recruits PCGF3/5-PRC1 to the xist RNA B-repeat to establish polycomb-mediated chromosomal silencing, Mol. Cell, 68, 955, 10.1016/j.molcel.2017.11.013 Xu, 2019, New insights into the interplay between non-coding RNAs and RNA-binding protein HnRNPK in regulating cellular functions, Cells, 8, 62, 10.3390/cells8010062 Simko, 2020, G-quadruplexes offer a conserved structural motif for NONO recruitment to NEAT1 architectural lncRNA, Nucleic Acids Res., 48, 7421 Yano, 2005, Involvement of Hu and heterogeneous nuclear ribonucleoprotein K in neuronal differentiation through p21 mRNA post-transcriptional regulation, J. Biol. Chem., 280, 12690, 10.1074/jbc.M411119200 Notari, 2006, A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation, Blood, 107, 2507, 10.1182/blood-2005-09-3732 Nguyen, 2020, The SINEB1 element in the long non-coding RNA Malat1 is necessary for TDP-43 proteostasis, Nucleic Acids Res., 48, 2621, 10.1093/nar/gkz1176 Taiana, 2020, LncRNA NEAT1 in paraspeckles: a structural scaffold for cellular DNA damage response systems?, Noncoding RNA, 6, 26, 10.3390/ncrna6030026 Yamazaki, 2018, Functional domains of NEAT1 architectural lncRNA induce paraspeckle assembly through phase separation, Mol. Cell, 70, 1038, 10.1016/j.molcel.2018.05.019 Naganuma, 2013, Paraspeckle formation during the biogenesis of long non-coding RNAs, RNA Biol., 10, 456, 10.4161/rna.23547 Hirose, 2012, Paraspeckles: possible nuclear hubs by the RNA for the RNA, Biomol. Concepts, 3, 415, 10.1515/bmc-2012-0017 Chung, 2014, Matrix metalloproteinase 12 is induced by heterogeneous nuclear ribonucleoprotein K and promotes migration and invasion in nasopharyngeal carcinoma, BMC Cancer, 14, 348, 10.1186/1471-2407-14-348 Gao, 2013, Heterogeneous nuclear ribonucleoprotein K (hnRNP-K) promotes tumor metastasis by induction of genes involved in extracellular matrix, cell movement, and angiogenesis, J. Biol. Chem., 288, 15046, 10.1074/jbc.M113.466136 Chen, 2019, Role of heterogeneous nuclear ribonucleoprotein K in tumor development, J. Cell Biochem., 120, 14296, 10.1002/jcb.28867 Gallardo, 2016, Aberrant hnRNP K expression: all roads lead to cancer, Cell Cycle, 15, 1552, 10.1080/15384101.2016.1164372 Wen, 2010, Higher expression of the heterogeneous nuclear ribonucleoprotein k in melanoma, Ann. Surg. Oncol., 17, 2619, 10.1245/s10434-010-1121-1 Hong, 2014, PTEN antagonises Tcl1/hnRNPK-mediated G6PD pre-mRNA splicing which contributes to hepatocarcinogenesis, Gut, 63, 1635, 10.1136/gutjnl-2013-305302 Chen, 2010, The antiapoptotic protein, FLIP, is regulated by heterogeneous nuclear ribonucleoprotein K and correlates with poor overall survival of nasopharyngeal carcinoma patients, Cell Death Differ., 17, 1463, 10.1038/cdd.2010.24 Ciarlo, 2012, Regulation of neuroendocrine differentiation by AKT/hnRNPK/AR/beta-catenin signaling in prostate cancer cells, Int. J. Cancer, 131, 582, 10.1002/ijc.26402 Wu, 2012, Heterogeneous ribonucleoprotein K and thymidine phosphorylase are independent prognostic and therapeutic markers for oral squamous cell carcinoma, Oral Oncol., 48, 516, 10.1016/j.oraloncology.2012.01.005 Zhou, 2010, Increased expression of the heterogeneous nuclear ribonucleoprotein K in pancreatic cancer and its association with the mutant p53, Int. J. Cancer, 126, 395, 10.1002/ijc.24744 Otoshi, 2015, Cytoplasmic accumulation of heterogeneous nuclear ribonucleoprotein K strongly promotes tumor invasion in renal cell carcinoma cells, PLoS One, 10, e0145769, 10.1371/journal.pone.0145769 Enge, 2009, MDM2-dependent downregulation of p21 and hnRNP K provides a switch between apoptosis and growth arrest induced by pharmacologically activated p53, Cancer Cell, 15, 171, 10.1016/j.ccr.2009.01.019 Moumen, 2005, hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage, Cell, 123, 1065, 10.1016/j.cell.2005.09.032 Lee, 2012, SUMOylation of hnRNP-K is required for p53-mediated cell-cycle arrest in response to DNA damage, EMBO J., 31, 4441, 10.1038/emboj.2012.293 Pelisch, 2012, DNA damage-induced heterogeneous nuclear ribonucleoprotein K sumoylation regulates p53 transcriptional activation, J. Biol. Chem., 287, 30789, 10.1074/jbc.M112.390120 Gallardo, 2015, hnRNP K is a haploinsufficient tumor suppressor that regulates proliferation and differentiation programs in hematologic malignancies, Cancer Cell, 28, 486, 10.1016/j.ccell.2015.09.001 Kang, 2019, The rational design of cell-penetrating peptides for application in delivery systems, Peptides, 121, 170149, 10.1016/j.peptides.2019.170149 Kardani, 2019, Cell penetrating peptides: the potent multi-cargo intracellular carriers, Expert Opin. Drug Deliv., 16, 1227, 10.1080/17425247.2019.1676720 Ruseska, 2020, Internalization mechanisms of cell-penetrating peptides, Beilstein J. Nanotechnol., 11, 101, 10.3762/bjnano.11.10 Feng, 2020, ANXA1derived peptides suppress gastric and colon cancer cell growth by targeting EphA2 degradation, Int. J. Oncol., 57, 1203 Thomas, 2020, Thermally targeted p50 peptide inhibits proliferation and induces apoptosis of breast cancer cell lines, Macromol. Biosci., 20, e2000170, 10.1002/mabi.202000170 Jaraiz-Rodriguez, 2020, Connexin43 peptide, TAT-Cx43266-283, selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo, Neuro Oncol., 22, 493, 10.1093/neuonc/noz243 Alcalde, 2020, Grb7-derived calmodulin-binding peptides inhibit proliferation, migration and invasiveness of tumor cells while they enhance attachment to the substrate, Heliyon, 6, e03922, 10.1016/j.heliyon.2020.e03922 Puvvula, 2021, Novel cell-penetrating peptides derived from scaffold-attachment- factor A inhibits cancer cell proliferation and survival, Front Oncol., 11, 621825, 10.3389/fonc.2021.621825 Puvvula, 2021, Inhibiting an RBM39/MLL1 epigenomic regulatory complex with dominant-negative peptides disrupts cancer cell transcription and proliferation, Cell Rep., 35, 109156, 10.1016/j.celrep.2021.109156 Bomsztyk, 2004, hnRNP K: one protein multiple processes, Bioessays, 26, 629, 10.1002/bies.20048 Barboro, 2014, Emerging roles of heterogeneous nuclear ribonucleoprotein K (hnRNP K) in cancer progression, Cancer Lett., 352, 152, 10.1016/j.canlet.2014.06.019 Yin, 2020, RNA-binding motifs of hnRNP K are critical for induction of antibody diversification by activation-induced cytidine deaminase, Proc. Natl. Acad. Sci. U S A, 117, 11624, 10.1073/pnas.1921115117 Fei, 2017, Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing, Proc. Natl. Acad. Sci. U S A, 114, E5207, 10.1073/pnas.1617467114 Chen, 2017, Heterogeneous nuclear ribonucleoprotein K is associated with poor prognosis and regulates proliferation and apoptosis in bladder cancer, J. Cell Mol. Med., 21, 1266, 10.1111/jcmm.12999 Derossi, 1998, Trojan peptides: the penetratin system for intracellular delivery, Trends Cell Biol., 8, 84, 10.1016/S0962-8924(98)80017-2 Nakamoto, 2020, hnRNPK recognition of the B motif of Xist and other biological RNAs, Nucleic Acids Res., 48, 9320, 10.1093/nar/gkaa677 Kiledjian, 1992, Primary structure and binding activity of the hnRNP U protein: binding RNA through RGG box, EMBO J., 11, 2655, 10.1002/j.1460-2075.1992.tb05331.x Ozdilek, 2017, Intrinsically disordered RGG/RG domains mediate degenerate specificity in RNA binding, Nucleic Acids Res., 45, 7984, 10.1093/nar/gkx460 Tang, 2014, Downregulation of hnRNP K by RNAi inhibits growth of human lung carcinoma cells, Oncol. Lett., 7, 1073, 10.3892/ol.2014.1832 Xu, 2018, The multifunctional RNA-binding protein hnRNPK is critical for the proliferation and differentiation of myoblasts, BMB Rep., 51, 350, 10.5483/BMBRep.2018.51.7.043 Wells, 2002, The identification of E2F1-specific target genes, Proc. Natl. Acad. Sci. U S A, 99, 3890, 10.1073/pnas.062047499 Swiatkowska, 2020, Regulation of the p53 expression profile by hnRNP K under stress conditions, RNA Biol., 17, 1402, 10.1080/15476286.2020.1771944 Lubelsky, 2018, Sequences enriched in Alu repeats drive nuclear localization of long RNAs in human cells, Nature, 555, 107, 10.1038/nature25757 Shin, 2018, Functional roles of heterogeneous nuclear ribonucleoprotein K in post-transcriptional gene regulation, Precision Future Med., 2, 158, 10.23838/pfm.2018.00107 Zarnack, 2013, Direct competition between hnRNP C and U2AF65 protects the transcriptome from the exonization of Alu elements, Cell, 152, 453, 10.1016/j.cell.2012.12.023 Pfister, 2019, Emerging role of the nucleolar stress response in autophagy, Front Cell Neurosci., 13, 156, 10.3389/fncel.2019.00156 Lynch, 2005, hnRNP K binds a core polypyrimidine element in the eukaryotic translation initiation factor 4E (eIF4E) promoter, and its regulation of eIF4E contributes to neoplastic transformation, Mol. Cell Biol., 25, 6436, 10.1128/MCB.25.15.6436-6453.2005 Puvvula, 2014, Long noncoding RNA PANDA and scaffold-attachment-factor SAFA control senescence entry and exit, Nat. Commun., 5, 5323, 10.1038/ncomms6323 Huarte, 2010, A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response, Cell, 142, 409, 10.1016/j.cell.2010.06.040 Thompson, 2016, Correction: hnRNP K coordinates transcriptional silencing by SETDB1 in embryonic stem cells, PLoS Genet., 12, e1006390, 10.1371/journal.pgen.1006390 Lu, 2016, Role and molecular mechanism of heterogeneous nuclear ribonucleoprotein K in tumor development and progression, Biomed. Rep., 4, 657, 10.3892/br.2016.642 Verchere, 1990, Comparative study of various polyols as complexing agents for the acidimetric titration of tungstate, Analyst, 115, 637, 10.1039/AN9901500637 Wang, 2015, Kruppel-like factor 4 induces apoptosis and inhibits tumorigenic progression in SK-BR-3 breast cancer cells, FEBS Open Bio., 5, 147, 10.1016/j.fob.2015.02.003 Preston, 1996, Induction of apoptosis by c-Fos protein, Mol. Cell Biol., 16, 211, 10.1128/MCB.16.1.211 Stains, 2005, Heterogeneous nuclear ribonucleoprotein K represses transcription from a cytosine/thymidine-rich element in the osteocalcin promoter, Biochem. J., 385, 613, 10.1042/BJ20040680 Kim, 2020, Gene expression amplification by nuclear speckle association, J. Cell Biol., 219, e201904046 West, 2014, The long noncoding RNAs NEAT1 and MALAT1 bind active chromatin sites, Mol. Cell, 55, 791, 10.1016/j.molcel.2014.07.012 Bao, 2015, The p53-induced lincRNA-p21 derails somatic cell reprogramming by sustaining H3K9me3 and CpG methylation at pluripotency gene promoters, Cell Res., 25, 80, 10.1038/cr.2014.165